In 1993 Bartolomei joined the faculty at the
Perelman School of Medicine at the University of Pennsylvania. She dedicated her career to understand genomic imprinting, an inheritance process that results in unequal expression of the maternal and paternal alleles of genes. Amongst these genes, Bartolomei has continued to study
H19. She found that when the gene was activated in the
blastocyst mouse models demonstrated maternal-specific expression. These mouse models allowed Bartolomei to identify that assisted reproductive technologies (including
in-vitro culture,
embryo transfer,
in vitro fertilisation and hormonal hyperstimulation) can contribute to errors in epigenetic gene regulation. She has investigated the role of the transcription factor
CTCF. She found that in the absence of
CTCF,
H19 becomes
hypermethylated and embryos die early in development. She went on to show that
CTCF was crucial in early development and very involved with gene activity. Her research has considered
X-inactivation in mice; the process by which female mice silence one
X chromosome to achieve the same X-linked expression as male mice. == Awards and honours ==